Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients
| العنوان: | Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients |
|---|---|
| المؤلفون: | G.H. de Weert-van Oene, Tom Sensky, C.P.F. van der Staak, C.A.J. de Jong, E.A.G. Joosten |
| المصدر: | Psychotherapy and Psychosomatics, 78, 4, pp. 245-253 Psychotherapy and Psychosomatics, 78, 245-253 |
| سنة النشر: | 2009 |
| مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Substance-Related Disorders, media_common.quotation_subject, medicine.medical_treatment, Decision Making, law.invention, Experimental Psychopathology and Treatment, Quality of life (healthcare), Randomized controlled trial, law, Surveys and Questionnaires, otorhinolaryngologic diseases, medicine, Humans, Psychiatry, Applied Psychology, Problem Solving, media_common, Psychotropic Drugs, Substance dependence, Cognitive Behavioral Therapy, business.industry, Addiction, Social environment, General Medicine, Abstinence, Middle Aged, medicine.disease, Mental health, Combined Modality Therapy, Cognitive behavioral therapy, Hospitalization, Psychiatry and Mental health, Clinical Psychology, Alcoholism, Q-Sort, Psychotherapy, Group, Quality of Life, Female, sense organs, Substance Abuse Treatment Centers, Patient Participation, business, Goals, Social Adjustment, Follow-Up Studies |
| الوصف: | Background: In the last decades, shared decision-making (SDM) models have been developed to increase patient involvement in treatment decisions. The purpose of this study was to evaluate a SDM intervention (SDMI) for patients dependent on psychoactive substances in addiction health care programs. The intervention consisted of a structured procedure to reach a treatment agreement and comprised 5 sessions. Methods: Clinicians in 3 treatment centres in the Netherlands were randomly assigned to the SDMI or a standard procedure to reach a treatment agreement. Results: A total of 220 substance-dependent patients receiving inpatient treatment were randomised either to the intervention (n = 111) or control (n = 109) conditions. Reductions in primary substance use (F(1, 124) = 248.38, p < 0.01) and addiction severity (F(8) = 27.76, p < 0.01) were found in the total population. Significant change was found in the total population regarding patients’ quality of life measured at baseline, exit and follow-up (F(2, 146) = 5.66, p < 0.01). On the European Addiction Severity Index, SDMI showed significantly better improvements than standard decision-making regarding drug use (F(1, 164) = 7.40, p < 0.01) and psychiatric problems (F(1, 164) = 5.91, p = 0.02) at 3-month follow-up. Conclusion: SDMI showed a significant add-on effect on top of a well-established 3-month inpatient intervention. SDMI offers an effective, structured, frequent and well-balanced intervention to carry out and evaluate a treatment agreement. |
| تدمد: | 0033-3190 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::018d81058c0d2852ade1bf736cd3d932 https://hdl.handle.net/2066/77399 |
| Rights: | RESTRICTED |
| رقم الانضمام: | edsair.doi.dedup.....018d81058c0d2852ade1bf736cd3d932 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 00333190 |
|---|